Efficacious anti-tumor therapeutic or vaccine approaches tested in murine models resulting in protection from tumors are characterized by strong Th1 polarization, M1 macrophage activation, a TNFα response, and an anti-tumor IFNγ-producing CD8+ CTL (187, 188, 190, 197). The gene discussed is IFNG; the disease is neoplasm.